Summit Therapeutics Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2017 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Summit Therapeutics Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2017 to Q2 2025.
  • Summit Therapeutics Inc. Common Stock, Value, Issued for the quarter ending June 30, 2025 was $7.43M, a 2.55% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $7.43M +$185K +2.55% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $7.42M +$396K +5.64% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $7.38M +$359K +5.12% Dec 31, 2024 10-Q 2025-08-11
Q3 2024 $7.37M +$393K +5.63% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $7.24M +$267K +3.83% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.02M +$44K +0.63% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $7.02M +$4.91M +233% Dec 31, 2023 10-K 2025-02-24
Q3 2023 $6.98M +$4.97M +247% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $6.98M +$6M +611% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $6.98M +$6M +611% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.11M +$1.13M +115% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $2.01M +$1.04M +106% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $981K +$7K +0.72% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $981K +$152K +18.3% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $980K +$154K +18.6% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $976K +$304K +45.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $974K +$302K +44.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $829K Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $826K +$154K +22.9% Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 $672K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $672K Jun 30, 2020 8-K 2020-09-29
Q4 2019 $672K +$351K +109% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $321K +$174K +118% Jan 31, 2019 8-K 2020-09-29
Q4 2017 $147K Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.